• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research and Markets: Analysis of the Major Therapeutic Areas Within the Ophthalmic Pharmaceutical Drugs Industry

Posted on: Thursday, 10 August 2006, 15:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c40502) has announced the addition of Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Opthalmic Pharmaceutical Drugs in US$ Million. The major therapeutic categories analyzed are Glaucoma, Anti-allergy, Anti-infective, Dry Eye, Anti-inflammation, and Back of Eye. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 62 companies including many key and niche players worldwide such as Acuity Pharmaceuticals, Akorn, Inc., Alcon Eye Care, Inc., Allergan, Inc., Bausch & Lomb, Inc., Inspire Pharmaceuticals, Inc., ISTA Pharmaceuticals, Inc., Novartis Pharma AG., Pfizer Inc., QLT, Inc., Santen Pharmaceutical Co., and Santen Inc.

Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1. Market Overview 2. Industry Trends and Issues 3. Growth Drivers 4. An Overview Of Ophthalmic Disorders 5. Pricing and Reimbursement Trends 6. Research and Development 7. FDA Regulations and Approvals 8. Clinical Trials 9. Product Innovations/Introductions 10. Recent Industry Activity 11. Focus on Select Global Players 12. Global Market Perspective II. MARKET 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest of World III. COMPETITION

Companies Mentioned

- Acuity Pharmaceuticals, Inc (USA) - Advanced Medical Optics, Inc (USA) - Advanced Vision Research, Inc (USA) - Akorn, Inc (USA) - Alcon, Inc (USA) - Alimera Sciences (USA) - Allergan, Inc (USA) - Alpharx, Inc (Canada) - Amoun Pharmaceutical Company SAE (Egypt) - Aurolab (India) - Bal Pharma Ltd (India) - Bausch And Lomb, Inc (USA) - Bohus Biotech AB (Sweden) - Cadila Pharmaceuticals Ltd (India) - Ciron Drugs & Pharmaceuticals (P) Ltd (India) - Concord Drugs Ltd (India) - Custom Rx Compounding Pharmacy (USA) - Cynacon/OCuSOFT (USA) - E Fougera & co (USA) - Farmak PubJSC (Ukraine) - Farmigea SpA (Italy) - Genaera Corporation (USA) - GenVec, Inc (USA) - Gland Pharma Ltd (India) - GSK Consumer Healthcare (Malaysia) - Hemomont doo (Serbia and Montenegro) - Hi-Tech Pharmacal Co, Inc (USA) - Indkus Drugs And Pharma Pvt, Ltd (India) - Insite Vision, Inc (USA) - Inspire Pharmaceuticals, Inc (USA) - ISTA Pharmaceuticals (USA) - Laboratorio Edol Produtos Farmaceuticos, SA (Portugal)- Medpointe, Inc (USA) - Merck & Co, Inc (USA) - Micro Labs (India) - Minapharm Pharmaceuticals (Egypt) - Miravant Medical Technology (USA) - Nascent Pharmaceuticals, Inc (USA) - Novagali Pharma SA (France): - Novartis AG (Switzerland) - NPS Pharmaceuticals (USA) - OSI Pharmaceuticals (USA) - Othera Pharmaceuticals (USA) - Otsuka Pharmaceutical (Japan) - Oxigene, Inc (USA) - Parenteral Drugs Ltd (India) - Pfizer, Inc (USA) - Pharma Stulln GmbH (Germany) - PharmaDanica A/S (Denmark) - Pharmaplant Biogalenica (Romania) - Pharmaster (France) - Polpharma SA Zaklady Farmaceutyczne (Poland) - QLT, Inc (Canada) - Rohto Pharmaceutical Company Ltd (Japan) - Sifi SpA (Italy) - Santen Pharmaceutical Co, Ltd (Japan) - Senju Pharmaceutical Co, Ltd (Japan) - SRS Pharmaceuticals Pvt, Ltd (INDIA) - Sucampo Pharmaceuticals, Inc (USA) - Unimed Pharma Sro (Slovakia) - Ursapharm Arzneimittel GmbH & Co, KG (Germany) - Vitamed Pharmaceutical Industries Ltd (Israel)

For more information visit http://www.researchandmarkets.com/reports/c40502

Source: Business Wire

More News in this Category